BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection

Fiorenza Orlando, Roberto Ghiselli, Oscar Cirioni, Daniele Minardi, Linda Tomasinsig, Federico Mocchegiani, Carmela Silvestri, Barbara Skerlavaj, Alessandra Riva, Giovanni Muzzonigro, Vittorio Saba, Giorgio Scalise, Margherita Zanetti, Andrea Giacometti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

An experimental study was performed to evaluate the efficacy of BMAP-28 alone and in combination with vancomycin in animal models ureteral stent infection due to Enterococcus faecalis and Staphylococcus aureus. Study included a control group without bacterial challenge to evaluate the sterility of surgical procedure, a challenged control group that did not receive any antibiotic prophylaxis and for each bacterial strain three challenged groups that received (a) 10 mg/kg vancomycin intraperitoneally, immediately after stent implantation, (b) BMAP-28-coated ureteral stents where 0.2-cm2 sterile ureteral stents were incubated in 1 mg/l BMAP-28 solution for 30 min immediately before implantation and (c) intraperitoneal vancomycin plus BMAP-28-coated ureteral stent at the above concentrations. Experiments were performed in duplicate. Ureteral stents were explanted at day 5 following implantation and biofilm bacteria enumerated. Our data showed that rats that received intraperitoneal vancomycin showed the lowest bacterial numbers. BMAP-28 combined with vancomycin showed efficacies higher than that of each single compound. These results highlight the potential usefulness of this combination in preventing ureteral stent-associated in gram-positive infections.

Original languageEnglish
Pages (from-to)1118-1123
Number of pages6
JournalPeptides
Volume29
Issue number7
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Gram-Positive Cocci
Stents
Vancomycin
Rats
Infection
Control Groups
Antibiotic Prophylaxis
Enterococcus faecalis
Biofilms
BMAP-28
Infertility
Staphylococcus aureus
Bacteria
Animals
Animal Models
Anti-Bacterial Agents

Keywords

  • Animal model
  • Biofilm
  • Cathelicidins
  • Gram-positive cocci
  • Ureteral stent

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Orlando, F., Ghiselli, R., Cirioni, O., Minardi, D., Tomasinsig, L., Mocchegiani, F., ... Giacometti, A. (2008). BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection. Peptides, 29(7), 1118-1123. https://doi.org/10.1016/j.peptides.2008.03.005

BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection. / Orlando, Fiorenza; Ghiselli, Roberto; Cirioni, Oscar; Minardi, Daniele; Tomasinsig, Linda; Mocchegiani, Federico; Silvestri, Carmela; Skerlavaj, Barbara; Riva, Alessandra; Muzzonigro, Giovanni; Saba, Vittorio; Scalise, Giorgio; Zanetti, Margherita; Giacometti, Andrea.

In: Peptides, Vol. 29, No. 7, 07.2008, p. 1118-1123.

Research output: Contribution to journalArticle

Orlando, F, Ghiselli, R, Cirioni, O, Minardi, D, Tomasinsig, L, Mocchegiani, F, Silvestri, C, Skerlavaj, B, Riva, A, Muzzonigro, G, Saba, V, Scalise, G, Zanetti, M & Giacometti, A 2008, 'BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection', Peptides, vol. 29, no. 7, pp. 1118-1123. https://doi.org/10.1016/j.peptides.2008.03.005
Orlando, Fiorenza ; Ghiselli, Roberto ; Cirioni, Oscar ; Minardi, Daniele ; Tomasinsig, Linda ; Mocchegiani, Federico ; Silvestri, Carmela ; Skerlavaj, Barbara ; Riva, Alessandra ; Muzzonigro, Giovanni ; Saba, Vittorio ; Scalise, Giorgio ; Zanetti, Margherita ; Giacometti, Andrea. / BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection. In: Peptides. 2008 ; Vol. 29, No. 7. pp. 1118-1123.
@article{60be5ab45ad34b38a5f53b8b5d29351a,
title = "BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection",
abstract = "An experimental study was performed to evaluate the efficacy of BMAP-28 alone and in combination with vancomycin in animal models ureteral stent infection due to Enterococcus faecalis and Staphylococcus aureus. Study included a control group without bacterial challenge to evaluate the sterility of surgical procedure, a challenged control group that did not receive any antibiotic prophylaxis and for each bacterial strain three challenged groups that received (a) 10 mg/kg vancomycin intraperitoneally, immediately after stent implantation, (b) BMAP-28-coated ureteral stents where 0.2-cm2 sterile ureteral stents were incubated in 1 mg/l BMAP-28 solution for 30 min immediately before implantation and (c) intraperitoneal vancomycin plus BMAP-28-coated ureteral stent at the above concentrations. Experiments were performed in duplicate. Ureteral stents were explanted at day 5 following implantation and biofilm bacteria enumerated. Our data showed that rats that received intraperitoneal vancomycin showed the lowest bacterial numbers. BMAP-28 combined with vancomycin showed efficacies higher than that of each single compound. These results highlight the potential usefulness of this combination in preventing ureteral stent-associated in gram-positive infections.",
keywords = "Animal model, Biofilm, Cathelicidins, Gram-positive cocci, Ureteral stent",
author = "Fiorenza Orlando and Roberto Ghiselli and Oscar Cirioni and Daniele Minardi and Linda Tomasinsig and Federico Mocchegiani and Carmela Silvestri and Barbara Skerlavaj and Alessandra Riva and Giovanni Muzzonigro and Vittorio Saba and Giorgio Scalise and Margherita Zanetti and Andrea Giacometti",
year = "2008",
month = "7",
doi = "10.1016/j.peptides.2008.03.005",
language = "English",
volume = "29",
pages = "1118--1123",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection

AU - Orlando, Fiorenza

AU - Ghiselli, Roberto

AU - Cirioni, Oscar

AU - Minardi, Daniele

AU - Tomasinsig, Linda

AU - Mocchegiani, Federico

AU - Silvestri, Carmela

AU - Skerlavaj, Barbara

AU - Riva, Alessandra

AU - Muzzonigro, Giovanni

AU - Saba, Vittorio

AU - Scalise, Giorgio

AU - Zanetti, Margherita

AU - Giacometti, Andrea

PY - 2008/7

Y1 - 2008/7

N2 - An experimental study was performed to evaluate the efficacy of BMAP-28 alone and in combination with vancomycin in animal models ureteral stent infection due to Enterococcus faecalis and Staphylococcus aureus. Study included a control group without bacterial challenge to evaluate the sterility of surgical procedure, a challenged control group that did not receive any antibiotic prophylaxis and for each bacterial strain three challenged groups that received (a) 10 mg/kg vancomycin intraperitoneally, immediately after stent implantation, (b) BMAP-28-coated ureteral stents where 0.2-cm2 sterile ureteral stents were incubated in 1 mg/l BMAP-28 solution for 30 min immediately before implantation and (c) intraperitoneal vancomycin plus BMAP-28-coated ureteral stent at the above concentrations. Experiments were performed in duplicate. Ureteral stents were explanted at day 5 following implantation and biofilm bacteria enumerated. Our data showed that rats that received intraperitoneal vancomycin showed the lowest bacterial numbers. BMAP-28 combined with vancomycin showed efficacies higher than that of each single compound. These results highlight the potential usefulness of this combination in preventing ureteral stent-associated in gram-positive infections.

AB - An experimental study was performed to evaluate the efficacy of BMAP-28 alone and in combination with vancomycin in animal models ureteral stent infection due to Enterococcus faecalis and Staphylococcus aureus. Study included a control group without bacterial challenge to evaluate the sterility of surgical procedure, a challenged control group that did not receive any antibiotic prophylaxis and for each bacterial strain three challenged groups that received (a) 10 mg/kg vancomycin intraperitoneally, immediately after stent implantation, (b) BMAP-28-coated ureteral stents where 0.2-cm2 sterile ureteral stents were incubated in 1 mg/l BMAP-28 solution for 30 min immediately before implantation and (c) intraperitoneal vancomycin plus BMAP-28-coated ureteral stent at the above concentrations. Experiments were performed in duplicate. Ureteral stents were explanted at day 5 following implantation and biofilm bacteria enumerated. Our data showed that rats that received intraperitoneal vancomycin showed the lowest bacterial numbers. BMAP-28 combined with vancomycin showed efficacies higher than that of each single compound. These results highlight the potential usefulness of this combination in preventing ureteral stent-associated in gram-positive infections.

KW - Animal model

KW - Biofilm

KW - Cathelicidins

KW - Gram-positive cocci

KW - Ureteral stent

UR - http://www.scopus.com/inward/record.url?scp=44649096832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649096832&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2008.03.005

DO - 10.1016/j.peptides.2008.03.005

M3 - Article

C2 - 18430491

AN - SCOPUS:44649096832

VL - 29

SP - 1118

EP - 1123

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 7

ER -